Clene Inc Net Income
| CLNN Stock | USD 4.45 0.16 3.73% |
As of the 10th of February, Clene shows the risk adjusted performance of (0.11), and Mean Deviation of 5.16. Clene Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Clene Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 298.6726 | Revenue | Earnings Share (3.44) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -35.5 M | -37.2 M | |
| Net Loss | -26.9 M | -28.3 M | |
| Net Loss | -35.5 M | -37.2 M | |
| Net Loss | (6.52) | (6.84) | |
| Net Income Per E B T | 0.86 | 0.91 |
Clene | Net Income | Build AI portfolio with Clene Stock |
Evaluating Clene's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Clene Inc's fundamental strength.
Latest Clene's Net Income Growth Pattern
Below is the plot of the Net Income of Clene Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Clene Inc financial statement analysis. It represents the amount of money remaining after all of Clene Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Clene's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clene's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (39.4 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Clene Net Income Regression Statistics
| Arithmetic Mean | (13,731,612) | |
| Coefficient Of Variation | (126.30) | |
| Mean Deviation | 14,974,084 | |
| Median | (277,311) | |
| Standard Deviation | 17,342,826 | |
| Sample Variance | 300.8T | |
| Range | 49.5M | |
| R-Value | (0.86) | |
| Mean Square Error | 83.5T | |
| R-Squared | 0.74 | |
| Slope | (2,953,802) | |
| Total Sum of Squares | 4812.4T |
Clene Net Income History
Other Fundumenentals of Clene Inc
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Clene Net Income component correlations
Clene Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Clene is extremely important. It helps to project a fair market value of Clene Stock properly, considering its historical fundamentals such as Net Income. Since Clene's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Clene's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Clene's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Clene diversify its offerings? Factors like these will boost the valuation of Clene. Projected growth potential of Clene fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Clene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.614 | Earnings Share (3.44) | Revenue Per Share | Quarterly Revenue Growth (0.83) | Return On Assets |
Understanding Clene Inc requires distinguishing between market price and book value, where the latter reflects Clene's accounting equity. The concept of intrinsic value - what Clene's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Clene's price substantially above or below its fundamental value.
It's important to distinguish between Clene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Clene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Clene's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Clene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Clene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Clene.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Clene on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Clene Inc or generate 0.0% return on investment in Clene over 90 days. Clene is related to or competes with MacroGenics, Ovid Therapeutics, Coya Therapeutics, Oramed Pharmaceuticals, Whitehawk Therapeutics, Context Therapeutics, and Zentalis Pharmaceuticals. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of nov... More
Clene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Clene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Clene Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 38.74 | |||
| Value At Risk | (15.07) | |||
| Potential Upside | 9.44 |
Clene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Clene's standard deviation. In reality, there are many statistical measures that can use Clene historical prices to predict the future Clene's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.29) | |||
| Total Risk Alpha | (1.88) | |||
| Treynor Ratio | (0.47) |
Clene February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.46) | |||
| Mean Deviation | 5.16 | |||
| Coefficient Of Variation | (673.49) | |||
| Standard Deviation | 7.25 | |||
| Variance | 52.55 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.29) | |||
| Total Risk Alpha | (1.88) | |||
| Treynor Ratio | (0.47) | |||
| Maximum Drawdown | 38.74 | |||
| Value At Risk | (15.07) | |||
| Potential Upside | 9.44 | |||
| Skewness | (0.80) | |||
| Kurtosis | 1.62 |
Clene Inc Backtested Returns
Clene Inc secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of standard deviation over the last 3 months. Clene Inc exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Clene's risk adjusted performance of (0.11), and Mean Deviation of 5.16 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.3, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Clene will likely underperform. At this point, Clene Inc has a negative expected return of -0.96%. Please make sure to confirm Clene's jensen alpha, as well as the relationship between the skewness and day median price , to decide if Clene Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.56 |
Modest predictability
Clene Inc has modest predictability. Overlapping area represents the amount of predictability between Clene time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Clene Inc price movement. The serial correlation of 0.56 indicates that roughly 56.0% of current Clene price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.56 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.53 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Clene Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Clene Inc reported net income of (39.4 Million). This is 111.54% lower than that of the Biotechnology sector and 156.25% lower than that of the Health Care industry. The net income for all United States stocks is 106.9% higher than that of the company.
Clene Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clene's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clene could also be used in its relative valuation, which is a method of valuing Clene by comparing valuation metrics of similar companies.Clene is currently under evaluation in net income category among its peers.
Clene ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Clene's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Clene's managers, analysts, and investors.Environmental | Governance | Social |
Clene Fundamentals
| Return On Equity | -17.38 | ||||
| Return On Asset | -0.56 | ||||
| Operating Margin | (376.53) % | ||||
| Current Valuation | 63.92 M | ||||
| Shares Outstanding | 11.78 M | ||||
| Shares Owned By Insiders | 28.61 % | ||||
| Shares Owned By Institutions | 17.18 % | ||||
| Number Of Shares Shorted | 752.82 K | ||||
| Price To Earning | 4.09 X | ||||
| Price To Book | 7.83 X | ||||
| Price To Sales | 236.12 X | ||||
| Revenue | 342 K | ||||
| Gross Profit | 176 K | ||||
| EBITDA | (33.69 M) | ||||
| Net Income | (39.4 M) | ||||
| Cash And Equivalents | 16.23 M | ||||
| Cash Per Share | 0.22 X | ||||
| Total Debt | 20.84 M | ||||
| Current Ratio | 3.49 X | ||||
| Book Value Per Share | (1.21) X | ||||
| Cash Flow From Operations | (21.33 M) | ||||
| Short Ratio | 7.19 X | ||||
| Earnings Per Share | (3.44) X | ||||
| Target Price | 32.0 | ||||
| Number Of Employees | 75 | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 50.53 M | ||||
| Total Asset | 27.34 M | ||||
| Retained Earnings | (282.12 M) | ||||
| Working Capital | 5.87 M | ||||
| Net Asset | 27.34 M |
About Clene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clene Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clene Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Clene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clene will appreciate offsetting losses from the drop in the long position's value.Moving together with Clene Stock
Moving against Clene Stock
| 0.81 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.77 | DSGN | Design Therapeutics | PairCorr |
| 0.71 | ENGN | enGene Holdings Common | PairCorr |
| 0.58 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.44 | 63E | ONWARD MEDICAL BV | PairCorr |
The ability to find closely correlated positions to Clene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clene Inc to buy it.
The correlation of Clene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clene Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Will Biotechnology sector continue expanding? Could Clene diversify its offerings? Factors like these will boost the valuation of Clene. Projected growth potential of Clene fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Clene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.614 | Earnings Share (3.44) | Revenue Per Share | Quarterly Revenue Growth (0.83) | Return On Assets |
Understanding Clene Inc requires distinguishing between market price and book value, where the latter reflects Clene's accounting equity. The concept of intrinsic value - what Clene's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Clene's price substantially above or below its fundamental value.
It's important to distinguish between Clene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Clene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Clene's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.